Cargando…

Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy

BACKGROUND: Childhood cancer survivors are potentially at a higher risk of infection with hepatitis C virus (HCV). The effects of all-oral direct-acting antiviral therapy (DAA) on both the HCV infection as well as the state of cancer remission have not been well investigated in this population. AIM:...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Shabrawi, Mortada HF, Sherief, Laila M, Yakoot, Mostafa, Kamal, Naglaa M, Almalky, Mohamed A, AbdElgawad, Manal M, Mahfouz, Aml A, Helmy, Sherine, Kamal, Enas M, Attia, Dina, El-Khayat, Hisham R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Prospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718790/ https://www.ncbi.nlm.nih.gov/pubmed/31531319 http://dx.doi.org/10.12998/wjcc.v7.i16.2247

Ejemplares similares

Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
por: Xue, Yan, et al.
Publicado: (2017)

Sofosbuvir and daclatasvir
por: Hessel, Marleen H. M., et al.
Publicado: (2016)

Response Tailored Protocol Versus the Fixed 12 Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial
por: Yakoot, Mostafa, et al.
Publicado: (2017)

Congenital chloride losing diarrhea: A single center experience in a highly consanguineous population
por: Kamal, Naglaa M., et al.
Publicado: (2019)

Hepatic effect of sofosbuvir and daclatasvir in thioacetamide-induced liver injury in rats
por: Ibrahim, Mohamed A., et al.
Publicado: (2018)

A clinical and immunological study of children with chronic hepatitis B virus infection
por: El-Shabrawi, Mortada, et al.
Publicado: (2019)

The Asia Pacific Pediatric Association (APPA) position statement on the MAFLD definition of fatty liver disease
por: Memon, Iqbal A., et al.
Publicado: (2023)

Acute Interstitial Nephritis Associated with Sofosbuvir and Daclatasvir
por: Ashraf, Taha, et al.
Publicado: (2017)

Pilot study of the efficacy and safety of lettuce seed oil in patients with sleep disorders
por: Yakoot, Mostafa, et al.
Publicado: (2011)

Facial Asymmetry in a Newly Born Baby: Diagnostic Challenge!
por: Kamal, Naglaa M, et al.
Publicado: (2022)

Perinatal transmission of hepatitis C virus: an update
por: El-Shabrawi, Mortada H.F., et al.
Publicado: (2019)

Case Report: Dubin-Johnson Syndrome Presenting With Infantile Cholestasis: An Overlooked Diagnosis in an Extended Family
por: Kamal, Naglaa M., et al.
Publicado: (2022)

A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019
por: Shabani, M., et al.
Publicado: (2021)

Novel homozygous mutation of PNLIP gene in congenital pancreatic lipase deficiency: an extended family study
por: Kamal, Naglaa M., et al.
Publicado: (2022)

Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
por: Hill, Andrew, et al.
Publicado: (2016)

Sofosbuvir/daclatasvir in the treatment of COVID-19 infection: A meta-analysis
por: Chan, Huan-Tee, et al.
Publicado: (2021)

Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
por: McEwan, Phil, et al.
Publicado: (2017)

Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over
por: Tamai, Hideyuki, et al.
Publicado: (2020)

Efficacy and safety of a herbal mixture (Viron(®) tablets) in the treatment of patients with chronic hepatitis C virus infection: a prospective, randomized, open-label, proof-of-concept study
por: Shawkat, Hisham, et al.
Publicado: (2015)

The ameliorating role of sofosbuvir and daclatasvir on thioacetamide-induced kidney injury in adult albino rats
por: Moustafa, Ahmed H., et al.
Publicado: (2023)

Treatment Outcomes for Patients Undergoing Hemodialysis with Chronic Hepatitis C on the Sofosbuvir and Daclatasvir Regimen
por: Butt, Nazish, et al.
Publicado: (2019)

Diagnosis of spontaneous bacterial peritonitis in infants and children with chronic liver disease: A cohort study
por: El-Shabrawi, Mortada HF, et al.
Publicado: (2011)

Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village
por: Ahmed, Ossama Ashraf, et al.
Publicado: (2018)

Outpatient Blind Percutaneous Liver Biopsy in Infants and Children: Is it Safe?
por: El-Shabrawi, Mortada H., et al.
Publicado: (2012)

Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
por: Yada, Masayoshi, et al.
Publicado: (2018)

Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience
por: Hassan, Amro M, et al.
Publicado: (2018)

Complete rectal prolapse in young Egyptian males: Is schistosomiasis really condemned?
por: Abou-Zeid, Ahmed A, et al.
Publicado: (2016)

Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C
por: de Medeiros, Lucas Pereira Jorge, et al.
Publicado: (2018)

A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients
por: Duerr, Michael, et al.
Publicado: (2019)

Effectiveness of Sofosbuvir and Daclatasvir in treatment of Hepatitis-C: An experience of tertiary care hospital in Karachi
por: Butt, Nazish, et al.
Publicado: (2021)

Efficacy of generic sofosbuvir with daclatasvir compared to sofosbuvir/ledipasvir in genotype 4 hepatitis C virus: A prospective comparison with historical control
por: Joharji, Hala, et al.
Publicado: (2022)

Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
por: Ahmed, Ossama A, et al.
Publicado: (2018)

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence
por: Poordad, Fred, et al.
Publicado: (2016)

Dramatic response of hepatitis C patients chronically infected with hepatitis C virus genotype 3 to sofosbuvir-based therapies in Punjab, Pakistan: A prospective study
por: Iqbal, Sajjad, et al.
Publicado: (2017)

Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection
por: Sokhela, Simiso, et al.
Publicado: (2022)

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients
por: Pellicelli, Adriano, et al.
Publicado: (2020)

Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan
por: Mushtaq, Saima, et al.
Publicado: (2020)

Video recording of neonatal resuscitation: A feasibility study to inform widespread adoption
por: Shivananda, Sandesh, et al.
Publicado: (2017)

High-resolution anorectal manometry in children with functional constipation: a single-centre experience before and after treatment
por: El-Shabrawi, Mortada, et al.
Publicado: (2018)

Effect of Memo®, a natural formula combination, on Mini-Mental State Examination scores in patients with mild cognitive impairment
por: Yakoot, Mostafa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kp5l5vcbqkk81e4e6mnvvilc2i